OPRX Stock Analysis: Buy, Sell, or Hold?
OPRX - OptimizeRx Corporation Common Stock
$4.98
-0.10 (-1.97%)
▼
5d:
-5.68%
30d:
+3.11%
90d:
-19.02%
HOLD
LOW Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When OPRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OPRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: OPRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.89
Based on 10.0% avg growth
INTRINSIC VALUE TODAY
$9.86
49.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPRX is currently trading at $4.98, which is considered slightly low relative to its 30-day fair value range of $4.86 to $5.43. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.6) compared to its historical average (9.1). Remarkably, the market is currently pricing in an annual earnings decline of 20.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OPRX is in a strong downtrend. Immediate support is located at $4.80, while resistance sits at $5.61.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.50 (+130.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OPRX is in a strong downtrend. Immediate support is located at $4.80, while resistance sits at $5.61.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.50 (+130.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.86 -
$5.43
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.5%
Protect Your Profits
Holding OPRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 130.9% below Wall St target ($11.50)
- CAUTION: Recommendation downgraded due to -5.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$4.86 -
$5.43
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.62
(12.5%)
Support & Resistance Levels
Support Level
$4.80
Resistance Level
$5.61
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.58
Wall Street Target
$11.50
(+130.9%)
Revenue Growth (YoY)
-9.5%
Earnings Growth (YoY)
-66.8%
Profit Margin
6.4%
Valuation Discount vs History
-20.6% cheaper
PE vs Historical
4.6 vs 9.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-20.6%
(market-implied from PE analysis)
1-Year Target
$4.48
(-10%)
2-Year Target
$4.03
(-19%)
3-Year Target
$3.63
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→9)
$7.22
(+45%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 16.0%)
$36.98
(+643%)
Base:
(SPY PE: 4.6, Growth: 16.0%)
$7.77
(+56%)
Bear:
(PE: 3.9, Growth: 16.0%)
$6.61
(+33%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (5x PE) as earnings recover.
Trailing PE: 14.11 | Current EPS (TTM): $0.36
Bull Case
$11.18
(+124%)
Analyst growth 100.0%, PE expands to 15.5
Base Case
$10.16
(+104%)
Market implied 100.0%, PE stable at 14.1
Bear Case
$3.45
(-31%)
Severe decline -20.0%, PE contracts to 12.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.6 to 9.1
Stabilization Target:
$9.90
(+98.8%)
PE Expansion Potential:
+98.8%
Share & Embed Analysis
Last updated: June 20, 2026 11:39 PM ET
Data refreshes hourly during market hours. Next update: 12:39 AM
Data refreshes hourly during market hours. Next update: 12:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 51 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 56 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 59 HOLD |
Advanced OPRX Option Strategies
Professional options setups generated by AI based on today's OPRX price and gamma walls.
